Abstract
The design and synthesis of analogs of galactosyl donors as potent and selective inhibitors of β-1,4-galactosyltransferase (β-1,4-GalT) are described. We employed a new strategy by incorporating 5-fluorouracil and an appropriate amino acid to galactose to prepare selective glycosyltransferase inhibitors. The in vitro cell assay showed that these compounds exhibited high cytotoxicity against the human leukemia cell line HL-60, human lung epithelial cell line A-549, and human liver cancer cell line BEL-7402, but low cytotoxicity against the murine leukemia cell line P388.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.